TAG:
cap
Dynacare’s Business Plan Includes New Direction
By Robert Michel | From the Volume VIII No. 1 – January 15, 2001 Issue
CEO SUMMARY: Look for Dynacare, Inc. to undergo a significant transformation. Although it will not abandon its efforts to partner with hospital laboratories, Dynacare has made a renewed commitment to expand and market itself as a provider of esoteric and reference testing. These changes a…
Consumers Taking Active Role In Their Laboratory Testing
By Robert Michel | From the Volume VIII No. 1 – January 15, 2001 Issue
CEO SUMMARY: Two recent Internet surveys revealed that consumers rank access to their personal lab test results as the number one most wanted feature in healthcare services. This is an early warning for laboratories and pathology group practices. Today’s consumers have changing expectat…
DNA Diagnostics Market, Kaiser Permanente, TriPath Imaging, LifeScan
By Robert Michel | From the Volume VIII No. 1 – January 15, 2001 Issue
DNA DIAGNOSTICS MARKET GROWTH TO BE DOMINATED BY PCR TECHNOLOGY FOR THE YEAR 2000, total DNA diagnostic technology sales were estimated to be $517 million. By 2005, this number should increase to $771 million, a growth rate of 8.4% per year. This is the conclusion of Laura Roth, author of â…
“January 15, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 1 – January 15, 2001 Issue
In Cincinnati, the CHIN (community healthcare information network) effort of the mid-1990s has evolved into HealthBridge, a “secure, private Intranet that provides physician access to hospital clinical records, insurance eligibility, e-mail, and on-line medical reference material.â…
Business Premises Underlying Lab Industry Dynamics
By Robert Michel | From the Volume VII No. 18 – December 25, 2000 Issue
This chapter addresses the characteristics of the laboratory industry which define the starting point for changes and ongoing evolution. The eight business premises listed in this White Paper describe unique situations which directly influence the ability of clinical laboratories to serve the medical…
Strategic Business Failures Of The Laboratory Industry During the 1990s
By Robert Michel | From the Volume VII No. 18 – December 25, 2000 Issue
If analysis is to be accurate and objective, it must recognize and praise successful accomplishments while at the same time recognizing and criticizing failures. Human nature being what it is, however, criticism of failed business decisions is painful and bound to generate denials by the parties invo…
Competitive Dynamics In the Laboratory Testing Marketplace
By Robert Michel | From the Volume VII No. 18 – December 25, 2000 Issue
This section of the White Paper deals with the marketplace for laboratory services. For brevity and clarity, I will address five components: 1) independent commercial laboratories; 2) hospital-based laboratories; 3) esoteric, reference, and specialty testing laboratories; 4) anatomic pathology lab- o…
Summary and Overview of Lab Industry
By Robert Michel | From the Volume VII No. 18 – December 25, 2000 Issue
If there is any common theme to the different chapters of this White Paper on the laboratory industry, it is probably this: in the next couple of years, clinical laboratories will continue to have one foot in the past and one foot in the future. Simply put, lab administrators will continue to manag…
Year’s Ten Biggest Stories Reveal Modest Changes
By Robert Michel | From the Volume VII No. 17 – December 4, 2000 Issue
CEO SUMMARY: In many ways, 2000 was a relatively quiet year for laboratory organizations. This list of the ten biggest stories in the lab industry for 2000 demonstrates that the most innovative laboratory organizations in the United States are “raising the bar†for service and quality…
Ortho-Clinical Diagnostics Embraces New Testing Technology
By Robert Michel | From the Volume VII No. 17 – December 4, 2000 Issue
CEO SUMMARY: Despite a decade of consolidation, competition among the world’s largest diagnostics manufacturers remains intense. In response to this competition, Ortho-Clinical Diagnostics (OCD) is preparing a variety of new products and services for its clinical laboratory customers. I…
CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized